Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features - Ray Chaudhuri - 2018 - Movement Disorders - Wiley Online Library
Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study - IOS Press
Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease
Clinical implications of gastric complications on levodopa treatment in Parkinson's disease - ScienceDirect
Carbidopa Levodopa - Uses, Dosage, and Side Effects
Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson's disease
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal
Cells | Free Full-Text | Levodopa-Induced Dyskinesia in Parkinson’s Disease: Pathogenesis and Emerging Treatment Strategies
Management and treatment of Parkinson's Disease - ppt video online download
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review | SpringerLink
Treating Parkinson's with Carbidopa/Levodopa – Journey with Parkinson's
Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact o
Drug Office - Oral Antiparkinsonian Drugs
Dr Ihab Suliman. دكتور ايهاب فتحي سليمان on Twitter: "#Levodopa side effects . It is used to treat ? https://t.co/BBHd2xYcg4" / Twitter
The Pharmacology of Parkinson's Disease - ppt video online download
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? | Philosophical Transactions of the Royal Society B: Biological Sciences
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies | Postgraduate Medical Journal
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial - The Lancet
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease | eNeuro
New Study Reports Levodopa Better than Other Drugs in the Long-term | Parkinson's Disease
Safinamide – A New Therapeutic Option to Address Motor Symptoms and Motor Complications in Mid- to Late-stage Parkinson's Disease - touchNEUROLOGY